Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 88.00
0.00 (0.00%)
Jul 9, 2026, 1:30 PM CST
Syngen Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,385 | 3,144 | 3,442 | 4,119 | 4,390 | 3,062 | |
Market Cap Growth | -34.08% | -8.66% | -16.45% | -6.17% | 43.36% | 4.63% |
Enterprise Value | 2,231 | 3,144 | 3,630 | 4,390 | 4,817 | 3,106 |
Last Close Price | 88.00 | 109.88 | 115.79 | 134.25 | 138.97 | 93.92 |
PE Ratio | 9.79 | 11.58 | 14.33 | 14.99 | 13.67 | 12.88 |
Forward PE | - | 13.20 | 13.20 | 13.20 | 13.20 | 13.20 |
PS Ratio | 1.15 | 1.47 | 1.71 | 2.24 | 2.27 | 2.08 |
PB Ratio | 1.05 | 1.33 | 1.54 | 1.93 | 2.20 | 1.73 |
P/TBV Ratio | 1.07 | 1.35 | 1.56 | 1.96 | 2.23 | 1.75 |
P/FCF Ratio | 7.35 | 12.28 | 11.96 | 12.74 | - | 11.14 |
P/OCF Ratio | 6.37 | 9.84 | 9.89 | 9.92 | 15.82 | 9.10 |
EV/Sales Ratio | 1.08 | 1.47 | 1.80 | 2.39 | 2.50 | 2.11 |
EV/EBITDA Ratio | 5.32 | 7.28 | 9.03 | 11.37 | 11.13 | 8.93 |
EV/EBIT Ratio | 7.42 | 9.62 | 11.97 | 14.50 | 13.29 | 11.03 |
EV/FCF Ratio | 6.88 | 12.29 | 12.61 | 13.58 | - | 11.30 |
Debt / Equity Ratio | 0.07 | 0.10 | 0.18 | 0.25 | 0.30 | 0.13 |
Debt / EBITDA Ratio | 0.40 | 0.50 | 0.95 | 1.34 | 1.34 | 0.65 |
Debt / FCF Ratio | 0.51 | 0.88 | 1.38 | 1.67 | - | 0.86 |
Net Debt / Equity Ratio | -0.07 | -0.02 | 0.03 | 0.08 | 0.18 | -0.04 |
Net Debt / EBITDA Ratio | -0.39 | -0.12 | 0.14 | 0.44 | 0.82 | -0.23 |
Net Debt / FCF Ratio | -0.48 | -0.20 | 0.20 | 0.53 | -1.16 | -0.29 |
Asset Turnover | 0.67 | 0.70 | 0.65 | 0.60 | 0.70 | 0.65 |
Inventory Turnover | 3.55 | 4.00 | 3.71 | 3.32 | 3.76 | 3.42 |
Quick Ratio | 1.10 | 1.42 | 1.47 | 1.29 | 1.00 | 1.68 |
Current Ratio | 1.84 | 2.20 | 2.22 | 1.94 | 1.55 | 2.43 |
Return on Equity (ROE) | 11.00% | 11.79% | 11.00% | 13.33% | 17.07% | 14.00% |
Return on Assets (ROA) | 6.04% | 6.67% | 6.12% | 6.13% | 8.26% | 7.75% |
Return on Invested Capital (ROIC) | 10.80% | 11.49% | 10.58% | 10.73% | 14.54% | 14.40% |
Return on Capital Employed (ROCE) | 12.20% | 12.90% | 11.80% | 12.00% | 15.40% | 14.10% |
Earnings Yield | 10.22% | 8.64% | 6.98% | 6.67% | 7.32% | 7.76% |
FCF Yield | 13.60% | 8.14% | 8.36% | 7.85% | -6.99% | 8.97% |
Dividend Yield | 5.68% | 4.55% | 4.32% | 3.72% | 3.60% | 4.26% |
Payout Ratio | 55.57% | 49.89% | 56.41% | 49.30% | 33.75% | 39.89% |
Buyback Yield / Dilution | -0.02% | -0.02% | - | 0.01% | 0.00% | 0.01% |
Total Shareholder Return | 5.70% | 4.53% | 4.32% | 3.74% | 3.60% | 4.27% |